Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
---|---|---|---|---|---|
TG2-H5253 | Human | Human TGF-beta RII / TGFBR2 Protein, Llama IgG2b Fc Tag (MALS verified) |
|
||
TG2-M82H5 | Mouse | Biotinylated Mouse TGF-beta RII / TGFBR2 Protein, His,Avitag™ |
|
||
TG2-H52H5 | Human | Human TGF-beta RII / TGFBR2 Protein, His Tag (MALS verified) |
|
||
TG2-H82E4 | Human | Biotinylated Human TGF-beta RII / TGFBR2 Protein, His,Avitag™ (HPLC verified) |
|
||
TG2-H82F6 | Human | Biotinylated Human TGF-beta RII / TGFBR2 Protein, Fc,Avitag™ (MALS verified) |
|
||
TG2-H5252 | Human | Human TGF-beta RII / TGFBR2 Protein, Fc Tag (MALS verified) |
|
Immobilized Human Latent TGFB1, His Tag (Cat. No. TG1-H524x) at 1 μg/mL (100 μL/well) can bind Biotinylated Mouse TGF-beta RII, His,Avitag (Cat. No. TG2-M82H5) with a linear range of 1-31 ng/mL (QC tested).
The purity of Human TGF-beta RII Protein, Llama IgG2b Fc Tag (Cat. No. TG2-H5253) is more than 85% and the molecular weight of this protein is around 95-115 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
HCW-9218 | HCW-9218 | Phase 2 Clinical | HCW Biologics Inc | Solid tumours; Pancreatic Neoplasms; Pulmonary Fibrosis | Details |
INCA33890 | INCA33890; INCA-33890 | Phase 1 Clinical | Incyte Corp | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |
RG-6315 | RG-6315 | Phase 1 Clinical | Genentech Inc | Scleroderma, Systemic | Details |
TASO-001 | TASO-001; ATB-301 | Phase 1 Clinical | Autotelicbio Co Ltd | Solid tumours | Details |
HCW-9218 | HCW-9218 | Phase 2 Clinical | HCW Biologics Inc | Solid tumours; Pancreatic Neoplasms; Pulmonary Fibrosis | Details |
INCA33890 | INCA33890; INCA-33890 | Phase 1 Clinical | Incyte Corp | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |
RG-6315 | RG-6315 | Phase 1 Clinical | Genentech Inc | Scleroderma, Systemic | Details |
TASO-001 | TASO-001; ATB-301 | Phase 1 Clinical | Autotelicbio Co Ltd | Solid tumours | Details |
This web search service is supported by Google Inc.